19 business development jobs found in Des Moines, IA

Bristol Myers Squibb is a global biopharmaceutical company committed to creating innovative medicines for millions of patients around the world fighting serious diseases in therapeutic areas such as oncology, hematology, immunology, cardiovascular and neuroscience. At the same time, we also nurture our own team with inspiring work and challenging career options.

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.

Axsome Therapeutics, Inc. is a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders. 

Axsome Therapeutics, Inc. is a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders. 

Axsome Therapeutics, Inc. is a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders. 

Mitsubishi Tanabe Pharma offers a unique opportunity to contribute to cutting-edge pharmaceutical innovation while being part of a company with over 300 years of history. Joining us means becoming a part of a global team dedicated to improving patient health through innovative therapies, particularly in the fields of neurology, immunology, and rare diseases. Our commitment to research and development, alongside our supportive and inclusive corporate culture, provides a dynamic and rewarding environment for professional growth. With a focus on ethical practices and sustainability, Mitsubishi Tanabe Pharma is not just a place to work, but a place to make a meaningful impact on global healthcare.

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.

For more than 125 years, Boehringer Ingelheim has been committed to the research and development of innovative medicines that help bring more health to patients and their families. As a privately-held, family-owned pharmaceutical company, Boehringer Ingelheim is able to take a long-term view and invest heavily in science.

Kyowa Kirin is a fast-growing global specialty pharmaceutical company that applies state-of-the-art biotechnologies to discover and deliver novel medicines in four disease areas: bone and mineral; intractable hematologic; hematology oncology; and rare disease. 

We are a focused biopharma company. We prevent and treat disease with vaccines, specialty and general medicines. We focus on the science of the immune system and advanced technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology).

We are a focused biopharma company. We prevent and treat disease with vaccines, specialty and general medicines. We focus on the science of the immune system and advanced technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology).

Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.

Working at Alexion is an experience like no other. With a focus on devastating and rare diseases, each endeavor is urgent and every day counts. You’ll have the opportunity to work on one of the most robust and exciting rare disease pipelines in the biopharmaceutical industry, which includes dozens of diverse preclinical programs across a range of therapeutic modalities. Ground-breaking innovation, life-saving therapies and a promising pipeline, all driven by a team with a shared sense of purpose and dedication – that’s Alexion. Join us to achieve the impossible and do what’s never been done before.

Working at Alexion is an experience like no other. With a focus on devastating and rare diseases, each endeavor is urgent and every day counts. You’ll have the opportunity to work on one of the most robust and exciting rare disease pipelines in the biopharmaceutical industry, which includes dozens of diverse preclinical programs across a range of therapeutic modalities. Ground-breaking innovation, life-saving therapies and a promising pipeline, all driven by a team with a shared sense of purpose and dedication – that’s Alexion. Join us to achieve the impossible and do what’s never been done before.

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.